Document
Assessing User Fees Under the Generic Drug User Fee Amendments of 2017 Guidance for Industry
ICR 202202-0910-011 · OMB 0910-0727 · Object 118747900.
This document may belong to an older filing. More recent activity for OMB 0910-0727:
Document Viewer [pdf]
Status: No verified local artifact is currently available. The document remains flagged for repair and upstream re-check.
Queue: Repair is queued and waiting for the next worker pass. (priority 80 · attempts 2 · next 2026-07-19 05:14:52)
Missing: pdf
No local or Spaces-backed artifact is available yet for this document.
Loading document viewer…
Document Metadata
| File Type | application/octet-stream |
|---|---|
| File Title | Assessing User Fees Under the Generic Drug User Fee Amendments of 2017 Guidance for Industry |
| Subject | Assessing User Fees Under the Generic Drug User Fee Amendments of 2017 Guidance for Industry |
| Author | FDA/CDER/Ladean.Rosenberg |
| File Modified | 2019-02-26 |
| File Created | 2017-10-26 |
| Conversion State | failed_conversion |